Jan 9 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:VRX) VRX.TO :
* Valeant to sell Dendreon to Sanpower Group for $819.9 million in cash
* Valeant Pharmaceuticals- co will use proceeds from sale of Dendreon to permanently repay term loan debt under its senior secured credit facility
* Valeant Pharmaceuticals International-affiliate entered agreement to sell all outstanding equity interests in Dendreon Pharma to Sanpower Group Source text for Eikon: ID:nPn8y32Yma Further company coverage: VRX.TO
(Bengaluru Newsroom)